Rene Caissie Research by SuperAGI

Rene Caissie

Company: Medeloop
LinkedIn: [linkedin.com/in/renecaissie](http://www.linkedin.com/in/renecaissie)

----

Executive Summary

Rene Caissie is the CEO and Co-Founder of Medeloop.ai, a pioneering medical research technology company leveraging artificial intelligence to transform clinical, public health, and life sciences research. His background spans 15 years in healthcare as a surgeon, researcher, entrepreneur, and innovator, and he has been instrumental in advancing AI applications in the field. Medeloop recently secured $15.5 million in Series A funding (November 2024) and previously raised $8 million in Seed funding, with support from General Catalyst. The company is based in Menlo Park, Montreal, and San Francisco.

Professional Profile

Current Roles

CEO & Co-Founder, Medeloop.ai

Founded in 2021, spurred by Caissie’s quest for innovative treatments for his daughter’s Complex Regional Pain Syndrome (CRPS), Medeloop.ai automates and accelerates the research process for clinical and public health studies using advanced AI agents. Caissie’s vision is to democratize and streamline research, reduce costs, and deliver real-world clinical impact.

Adjunct Professor, Stanford University School of Medicine

Teaches healthcare entrepreneurship, actively mentors Master’s students in Clinical Informatics Management, and contributes to high-profile initiatives such as the XPRIZE Brain Trust Team focused on advancing healthcare breakthroughs.

Venture Partner, OVO Fund

Supports early-stage investments in health and technology.

Previous Experience

Chief of Maxillofacial Surgery, Montreal HSC

National Board Examiner and Fellow of the Royal College, with a published research portfolio in nerve regeneration and clinical surgery.

University of Montreal & McGill University

Held professorship and research roles.

Founder, Medesync EMR

Developed an electronic medical record platform, later acquired by publicly traded telecom leader Telus (~$37B market cap).

Co-Founder, Dorma Filtration

Launched Canada’s first reusable N95 mask during the COVID-19 pandemic.

Inventor, Powered Full Head Protective Hood with Air Purifying Respirator

Developed essential medical PPE during the global health crisis.

Notable Ventures and Impact

Medeloop.ai:

Offers AI-powered platforms—Analytics Genius, Studies Genius, and Grants Genius—that enable:

No-code massive data analysis, biostatistics, and visualization

Automated, AI-driven study set-up, recruitment, monitoring, and compliance

AI-guided grant writing, opportunity identification, and document management

Use cases include working with large health systems, public health agencies, and academic research organizations.
Medeloop’s AI has already been adopted by organizations such as the New York City Department of Health and Mental Hygiene for public health analyses.

Strategic Partnerships:

HealthVerity (2025): Jointly enhancing real-world evidence (RWE) generation with AI-driven analytics.

Mila (Quebec AI Institute): Collaborating to advance AI in healthcare research.

Industry Thought Leader & Speaker:

Frequent panelist at healthcare and AI innovation events.

Recent podcasts: “Think Big and Things Happen” (Aspiriant), “Pfeffer on Power” (Stanford GSB).

Covered in major outlets, including Politico, Axios, GlobeNewswire, Business Insider, and PR Newswire.

NGO and Social Impact:

Founder, Volte-Face: NGO providing over $1M in free surgeries for underprivileged patients.

Board Member, Sprouts: Supporting skills development and coaching for disadvantaged youth.

Academic & Professional Credentials

Fellow, Royal College of Dentists of Canada (Maxillofacial Surgery)

National Board Examiner, Maxillofacial Surgery

Sloan Fellow, Stanford University Graduate School of Business (Recent)

Teaching Appointments:

Stanford University (adjunct professor)

McGill University

University of Montreal

Research Focus:

Nerve regeneration

AI and big data in clinical research

Clinical informatics and health systems innovation

Select Achievements and Media Mentions

$15.5M Series A Funding (2024): Advanced growth and further AI platform development

$8M Seed Funding (2023): Early acceleration with backing from General Catalyst

Medesync EMR Platform Acquisition: Demonstrated previous founder exit to a Fortune 500 company

Multiple patents and medical inventions, notably for pandemic response

Ongoing real-world deployments of Medeloop AI in leading public health settings

Personal & Professional Interests

Innovation in medical technology and AI-driven knowledge discovery

Humanitarian and nonprofit work: Over $1M in donated medical care

Sports & Adventure: Accomplished mountain climber, ocean racer, Ironman World Championship qualifier, and SR22 Turbo aircraft pilot

Contact and Location

Company Headquarters:

Menlo Park, CA | Montreal, QC | San Francisco, CA

Primary Email: info@medeloop.ai

LinkedIn: [Rene Caissie](http://www.linkedin.com/in/renecaissie)

Key Insights for Engagement

Decision-maker and visionary for digital health and AI-driven research solutions

Direct influencer in partnerships, funding, product innovation, and client acquisition at Medeloop

Strong network spanning academia, venture capital, public health agencies, and industry innovators

Focused on expanding AI applications for clinical, real-world, and public health research with an emphasis on compliance, scalability, and data democratization